carbon monoxide has been researched along with Colitis in 20 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The inhalation of carbon monoxide (CO) gas and the administration of CO-releasing molecules were shown to inhibit the development of intestinal inflammation in a murine colitis model." | 8.02 | Rectal administration of carbon monoxide inhibits the development of intestinal inflammation and promotes intestinal wound healing via the activation of the Rho-kinase pathway in rats. ( Higashimura, Y; Ishikawa, T; Itoh, Y; Kamada, K; Katada, K; Mizushima, K; Naito, Y; Okayama, T; Takagi, T; Uchiyama, K, 2021) |
| "Carbon monoxide (CO) is an endogenous signal transmitter involved in numerous physiological processes including the gastrointestinal (GI) homeostasis." | 5.43 | Prevention of colitis by controlled oral drug delivery of carbon monoxide. ( Botov, S; Gutmann, M; Hermann, C; Higashimura, Y; Meinel, L; Mizushima, K; Naito, Y; Schmalz, HG; Steiger, C; Takagi, T; Uchiyama, K, 2016) |
| "Acute colitis was induced with 2% DSS in male C57BL/6 mice." | 5.37 | Carbon monoxide liberated from carbon monoxide-releasing molecule exerts an anti-inflammatory effect on dextran sulfate sodium-induced colitis in mice. ( Handa, O; Hayashi, N; Hirata, I; Ichikawa, H; Ishikawa, T; Kokura, S; Mizushima, K; Naito, Y; Suzuki, T; Takagi, T; Tsuboi, H; Uchiyama, K; Yagi, N; Yoshikawa, T, 2011) |
| "The inhalation of carbon monoxide (CO) gas and the administration of CO-releasing molecules were shown to inhibit the development of intestinal inflammation in a murine colitis model." | 4.02 | Rectal administration of carbon monoxide inhibits the development of intestinal inflammation and promotes intestinal wound healing via the activation of the Rho-kinase pathway in rats. ( Higashimura, Y; Ishikawa, T; Itoh, Y; Kamada, K; Katada, K; Mizushima, K; Naito, Y; Okayama, T; Takagi, T; Uchiyama, K, 2021) |
| "Heme oxygenase-1 (HO-1) and its metabolic by-product, carbon monoxide (CO), protect against intestinal inflammation in experimental models of colitis, but little is known about their intestinal immune mechanisms." | 3.79 | Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance. ( Borst, LB; Hansen, JJ; Kobayashi, T; Mackey, LC; Maharshak, N; Moeser, AJ; Onyiah, JC; Otterbein, LE; Plevy, SE; Rawls, JF; Russo, SM; Sheikh, SZ; Steinbach, EC, 2013) |
| "Carbon monoxide (CO) has long been considered a toxic gas but is now a recognized bioactive gasotransmitter with potent immunomodulatory effects." | 1.72 | Delivery of therapeutic carbon monoxide by gas-entrapping materials. ( Aragon, A; Becker, SL; Bi, J; Bosch, DE; Boyce, H; Byrne, JD; Coleman, MC; Cotoia, AT; Csizmadia, E; Feig, VR; Gallo, D; Hayward, A; Ishida, K; Jeck, WR; Jenkins, J; Kezar, KM; Kim, H; Kuosmanen, JLP; Langer, R; Lee, GR; Lee, JS; Longhi, MS; Lopes, A; Otterbein, LE; Shankar, S; Spitz, DR; Steiger, C; Tift, M; Traverso, G; Wainer, J; Wentworth, AJ; Witt, E; Wong, K, 2022) |
| "Carbon monoxide (CO) has emerged as an important regulator of acute and chronic inflammation of the gastrointestinal tract." | 1.43 | Multiple targets of carbon monoxide gas in the intestinal inflammation. ( Katada, K; Naito, Y; Takagi, T; Uchiyama, K; Yoshikawa, T, 2016) |
| "Acute colitis was induced with 2% DSS in male C57BL/6 mice." | 1.37 | Carbon monoxide liberated from carbon monoxide-releasing molecule exerts an anti-inflammatory effect on dextran sulfate sodium-induced colitis in mice. ( Handa, O; Hayashi, N; Hirata, I; Ichikawa, H; Ishikawa, T; Kokura, S; Mizushima, K; Naito, Y; Suzuki, T; Takagi, T; Tsuboi, H; Uchiyama, K; Yagi, N; Yoshikawa, T, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 15 (75.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byrne, JD | 1 |
| Gallo, D | 1 |
| Boyce, H | 1 |
| Becker, SL | 1 |
| Kezar, KM | 1 |
| Cotoia, AT | 1 |
| Feig, VR | 1 |
| Lopes, A | 1 |
| Csizmadia, E | 1 |
| Longhi, MS | 1 |
| Lee, JS | 1 |
| Kim, H | 1 |
| Wentworth, AJ | 1 |
| Shankar, S | 1 |
| Lee, GR | 1 |
| Bi, J | 1 |
| Witt, E | 1 |
| Ishida, K | 1 |
| Hayward, A | 1 |
| Kuosmanen, JLP | 1 |
| Jenkins, J | 1 |
| Wainer, J | 1 |
| Aragon, A | 1 |
| Wong, K | 1 |
| Steiger, C | 2 |
| Jeck, WR | 1 |
| Bosch, DE | 1 |
| Coleman, MC | 1 |
| Spitz, DR | 1 |
| Tift, M | 1 |
| Langer, R | 1 |
| Otterbein, LE | 4 |
| Traverso, G | 1 |
| Takagi, T | 8 |
| Naito, Y | 8 |
| Higashimura, Y | 2 |
| Uchiyama, K | 7 |
| Okayama, T | 2 |
| Mizushima, K | 6 |
| Katada, K | 3 |
| Kamada, K | 2 |
| Ishikawa, T | 3 |
| Itoh, Y | 3 |
| Taguchi, K | 2 |
| Yamasaki, K | 2 |
| Sakai, H | 2 |
| Maruyama, T | 2 |
| Otagiri, M | 2 |
| Tanaka, M | 1 |
| Ushiroda, C | 1 |
| Toyokawa, Y | 1 |
| Hamaguchi, M | 1 |
| Handa, O | 4 |
| Uddin, MJ | 2 |
| Jeong, SO | 1 |
| Zheng, M | 2 |
| Chen, Y | 2 |
| Cho, GJ | 2 |
| Chung, HT | 2 |
| Joe, Y | 2 |
| Fukuda, W | 1 |
| Yoshida, N | 1 |
| Konishi, H | 1 |
| Yagi, N | 2 |
| Ichikawa, H | 3 |
| Yoshikawa, T | 5 |
| Cepinskas, G | 1 |
| Kim, HJ | 1 |
| Yoon, NA | 1 |
| Park, JW | 1 |
| Yin, H | 1 |
| Fang, J | 1 |
| Liao, L | 1 |
| Nakamura, H | 1 |
| Maeda, H | 1 |
| Nagao, S | 1 |
| Miyazaki, Y | 1 |
| Wakayama, T | 1 |
| Chuang, VT | 1 |
| Watanabe, H | 1 |
| Gutmann, M | 1 |
| Hermann, C | 1 |
| Botov, S | 1 |
| Schmalz, HG | 1 |
| Meinel, L | 1 |
| Ji, X | 1 |
| Zhou, C | 1 |
| Ji, K | 1 |
| Aghoghovbia, RE | 1 |
| Pan, Z | 1 |
| Chittavong, V | 1 |
| Ke, B | 1 |
| Wang, B | 1 |
| Akagiri, S | 1 |
| Suzuki, T | 2 |
| Hirata, I | 2 |
| Omatsu, T | 1 |
| Kokura, S | 2 |
| Tsuboi, H | 1 |
| Hayashi, N | 1 |
| Sheikh, SZ | 2 |
| Hegazi, RA | 2 |
| Kobayashi, T | 2 |
| Onyiah, JC | 2 |
| Russo, SM | 2 |
| Matsuoka, K | 1 |
| Sepulveda, AR | 2 |
| Li, F | 1 |
| Plevy, SE | 3 |
| Maharshak, N | 1 |
| Steinbach, EC | 1 |
| Mackey, LC | 1 |
| Hansen, JJ | 1 |
| Moeser, AJ | 1 |
| Rawls, JF | 1 |
| Borst, LB | 1 |
| Rao, KN | 1 |
| Mayle, A | 1 |
| Bach, FH | 1 |
| Chatterjee, PK | 1 |
2 reviews available for carbon monoxide and Colitis
| Article | Year |
|---|---|
The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders.
Topics: Animals; Biomimetics; Blood Substitutes; Carbon Monoxide; Colitis; Hemoglobins; Humans; Lung Disease | 2017 |
Therapeutic potential of carbon monoxide (CO) for intestinal inflammation.
Topics: Animals; Anti-Inflammatory Agents; Carbon Monoxide; Colitis; Humans; Inflammatory Bowel Diseases | 2012 |
18 other studies available for carbon monoxide and Colitis
| Article | Year |
|---|---|
Delivery of therapeutic carbon monoxide by gas-entrapping materials.
Topics: Animals; Carbon Monoxide; Colitis; Gases; Inflammation; Inflammatory Bowel Diseases; Swine | 2022 |
Rectal administration of carbon monoxide inhibits the development of intestinal inflammation and promotes intestinal wound healing via the activation of the Rho-kinase pathway in rats.
Topics: Administration, Rectal; Animals; Carbon Monoxide; Cells, Cultured; Chemokine CXCL1; Colitis; Colon; | 2021 |
Carbon monoxide ameliorates murine T-cell-dependent colitis through the inhibition of Th17 differentiation.
Topics: Animals; Carbon Monoxide; Cell Differentiation; Colitis; Female; Mice; Mice, Inbred BALB C; Mice, SC | 2018 |
Carbon monoxide attenuates dextran sulfate sodium-induced colitis via inhibition of GSK-3β signaling.
Topics: Animals; Body Weight; Bone Marrow Cells; Carbon Monoxide; Cell Line; Colitis; Colon; Cytokines; Dext | 2013 |
Anti-inflammatory effects of carbon monoxide-releasing molecule on trinitrobenzene sulfonic acid-induced colitis in mice.
Topics: Animals; Antimetabolites; Carbon Monoxide; Colitis; Colon; Cytokines; Gene Expression Regulation; Ma | 2014 |
Tristetraprolin mediates anti-inflammatory effect of carbon monoxide against DSS-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Carbon Monoxide; Cell Line; Colitis; Dextran Sulfate; Female; Gen | 2014 |
Styrene-maleic acid copolymer-encapsulated CORM2, a water-soluble carbon monoxide (CO) donor with a constant CO-releasing property, exhibits therapeutic potential for inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carbon Monoxide; Colitis; Colon; Cytokines; Dextran | 2014 |
Multiple targets of carbon monoxide gas in the intestinal inflammation.
Topics: Animals; Carbon Monoxide; Cell Differentiation; Colitis; Cytokines; Humans; Intestinal Mucosa; Lymph | 2016 |
Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Carbon Monoxide; Colitis; Dextran Sulfate; Disease Models, Animal | 2016 |
Prevention of colitis by controlled oral drug delivery of carbon monoxide.
Topics: Administration, Oral; Animals; Carbon Monoxide; Cell Survival; Colitis; Dose-Response Relationship, | 2016 |
Click and Release: A Chemical Strategy toward Developing Gasotransmitter Prodrugs by Using an Intramolecular Diels-Alder Reaction.
Topics: Animals; Anti-Inflammatory Agents; Carbon Monoxide; Colitis; Cycloaddition Reaction; Gasotransmitter | 2016 |
Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-α expression.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Antibodies; Carbon Monoxide; CD28 Ant | 2010 |
Carbon monoxide liberated from carbon monoxide-releasing molecule exerts an anti-inflammatory effect on dextran sulfate sodium-induced colitis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Monoxide; Chemotactic Factors; Colitis; Col | 2011 |
An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis.
Topics: Animals; Blotting, Western; Carbon Monoxide; Cell Separation; Colitis; Cytokines; Disease Models, An | 2011 |
Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance.
Topics: Animals; Bacterial Translocation; Blotting, Western; Carbon Monoxide; Colitis; Disease Models, Anima | 2013 |
Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway.
Topics: Administration, Inhalation; Animals; Carbon Monoxide; Colitis; DNA Primers; Enzyme Induction; Enzyme | 2005 |
Carbon monoxide: from the origin of life to molecular medicine.
Topics: Animals; Anti-Inflammatory Agents; Biliverdine; Carbon Monoxide; Colitis; Ferritins; Heme; Heme Oxyg | 2006 |
Physiological activities of carbon monoxide-releasing molecules: Ca ira.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Carbon Monoxide; Cell Transformation, Ne | 2007 |